Analystreport

Atara Biotherapeutics, Inc. (NASDAQ: ATRA) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating.

Atara Biotherapeutics, Inc.  (ATRA) 
Last atara biotherapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.atarabio.com/investor-relations